$198 Million is the total value of EPIQ Capital Group, LLC's 55 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 5.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWB | Sell | ISHARES TRrus 1000 etf | $43,752,108 | +1.5% | 179,503 | -6.2% | 22.05% | +1.7% |
VTI | Sell | VANGUARD INDEX FDStotal stk mkt | $33,754,137 | +4.5% | 153,233 | -3.2% | 17.01% | +4.7% |
ACWI | Sell | ISHARES TRmsci acwi etf | $30,554,865 | +2.9% | 318,479 | -2.2% | 15.40% | +3.0% |
IAU | Sell | ISHARES GOLD TRishares new | $18,994,779 | -14.0% | 521,978 | -11.7% | 9.57% | -13.9% |
GLD | Sell | SPDR GOLD TR | $14,700,501 | -5.7% | 82,462 | -3.1% | 7.41% | -5.5% |
VT | Sell | VANGUARD INTL EQUITY INDEX Ftt wrld st etf | $3,755,481 | +3.9% | 38,724 | -1.3% | 1.89% | +4.1% |
BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $3,725,828 | -27.8% | 44,701 | -11.4% | 1.88% | -27.6% |
JD | Sell | JD.COM INCspon adr cl a | $3,504,477 | -24.3% | 102,680 | -2.7% | 1.77% | -24.2% |
APP | Sell | APPLOVIN CORP | $2,549,534 | +52.5% | 99,088 | -6.6% | 1.28% | +52.8% |
AMTI | Sell | APPLIED MOLECULAR TRANS INC | $2,243,120 | -37.6% | 8,694,264 | -0.3% | 1.13% | -37.5% |
CRTX | Sell | QUINCE THERAPEUTICS INC | $1,404,436 | -6.1% | 933,180 | -2.6% | 0.71% | -5.9% |
SNOW | Sell | SNOWFLAKE INCcl a | $677,347 | -32.8% | 3,849 | -41.1% | 0.34% | -32.7% |
COIN | Sell | COINBASE GLOBAL INC | $305,018 | +4.5% | 4,263 | -1.3% | 0.15% | +4.8% |
CXM | Sell | SPRINKLR INCcl a | $241,071 | -42.8% | 17,431 | -46.4% | 0.12% | -42.5% |
Sell | TOAST INCcl a | $241,928 | -34.0% | 10,719 | -48.1% | 0.12% | -33.7% | |
OPEN | Sell | OPENDOOR TECHNOLOGIES INC | $95,519 | +64.6% | 23,761 | -27.9% | 0.05% | +65.5% |
Sell | OWLET INC | $22,705 | -2.4% | 66,759 | -6.9% | 0.01% | -8.3% | |
U | Exit | UNITY SOFTWARE INC | $0 | – | -6,607 | -100.0% | -0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
QUINCE THERAPEUTICS INC | 16 | Q3 2023 | 43.2% |
ISHARES TR | 16 | Q3 2023 | 22.1% |
ISHARES TR | 16 | Q3 2023 | 15.5% |
VANGUARD INDEX FDS | 16 | Q3 2023 | 17.0% |
SPDR GOLD TRUST | 16 | Q3 2023 | 8.4% |
ALIBABA GROUP HLDG LTD | 16 | Q3 2023 | 8.0% |
JD.COM INC | 16 | Q3 2023 | 3.3% |
VANGUARD TAX-MANAGED INTL FD | 16 | Q3 2023 | 2.7% |
VANGUARD INTL EQUITY INDEX F | 16 | Q3 2023 | 1.9% |
SPDR S&P 500 ETF TR | 16 | Q3 2023 | 1.6% |
View EPIQ Capital Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Lucira Health, Inc.Sold out | December 22, 2022 | 0 | 0.0% |
View EPIQ Capital Group, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-09 |
SC 13D/A | 2024-01-05 |
4 | 2023-12-29 |
13F-HR | 2023-11-08 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-11 |
13F-HR/A | 2023-02-14 |
13F-HR | 2023-02-13 |
SC 13D/A | 2022-12-22 |
View EPIQ Capital Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.